Company intelligence / Profile preview

Bend Research

Bend, Oregon, United States

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Bend Research, now part of Lonza, is a leading provider of pharmaceutical development and manufacturing technologies, notably for small molecules and increasing bioavailability through proprietary solvent and dispersion techniques. The firm has a history of innovation in drug delivery with successful collaborations and platforms in commercial use, but does not itself conduct clinical trials

Therapeutic areas: Other
Modalities: Small moleculeBiologicMonoclonal antibodyNanoparticleVaccine
Industry: Drug Discovery Services

Partnerships

Pfizer (exclusive contract, joint technology development)BASFQuotient Clinical

Beyond the preview

Go deeper on Bend Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bend Research.

Explore the full profile